Novel site-specific PEGylated L-asparaginase.

Novel site-specific PEGylated L-asparaginase.

L-asparaginase (ASNase) from Escherichia coli is currently used in some countries in its PEGylated form (ONCASPAR, pegaspargase) to treat acute lymphoblastic leukemia (ALL). PEGylation refers to the covalent attachment of poly(ethylene) glycol to the protein drug and it not only reduces the immune s...

Full description

Bibliographic Details
Main Authors:	Giovanna Pastore Meneguetti, João Henrique Picado Madalena Santos, Karin Mariana Torres Obreque, Christiano Marcello Vaz Barbosa, Gisele Monteiro, Sandra Helena Poliselli Farsky, Adriano Marim de Oliveira, Claudia Blanes Angeli, Giuseppe Palmisano, Sónia Patrícia Marques Ventura, Adalberto Pessoa-Junior, Carlota de Oliveira Rangel-Yagui
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2019-01-01
Series:	PLoS ONE
Online Access:	https://doi.org/10.1371/journal.pone.0211951

Similar Items

Correction: Novel site-specific PEGylated L-asparaginase.
by: Giovanna Pastore Meneguetti, et al.
Published: (2019-01-01)

Peg-Grafted Liposomes for L-Asparaginase Encapsulation
by: Marina de Souza Guimarães, et al.
Published: (2022-08-01)

Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles
by: Larissa Pereira Brumano, et al.
Published: (2019-01-01)

From Synthesis to Characterization of Site-Selective PEGylated Proteins
by: Lisandra Herrera Belén, et al.
Published: (2019-12-01)

Lysine-PEGylated Cytochrome C with Enhanced Shelf-Life Stability
by: João H. P. M. Santos, et al.
Published: (2022-02-01)

Severe Hypertriglyceridemia Associated with Pegylated Asparaginase Successfully Treated with Plasma Exchange
by: Rafael-Emmanuel Cuevas, et al.
Published: (2022-08-01)

Laporan kasus berbasis bukti: Reaksi hipersensitivitas terhadap pegylated asparaginase dibandingkan L-asparaginase pada anak dengan leukemia limfoblastik akut
by: Miranti Fristy Medyatama, et al.
Published: (2022-02-01)

In Silico Design of a Chimeric Humanized L-asparaginase
by: Alejandro Pedroso, et al.
Published: (2023-04-01)

Two-Step Purification of L-Asparaginase from Acrylaway® L
by: Louise Lacalendola Tundisi, et al.
Published: (2022-08-01)

Challenges for the Self-Assembly of Poly(Ethylene Glycol)–Poly(Lactic Acid) (PEG-PLA) into Polymersomes: Beyond the Theoretical Paradigms
by: Alexsandra Conceição Apolinário, et al.
Published: (2018-05-01)

Outcomes and adverse events in older acute lymphoblastic Leukemia patients treated with a pediatric-inspired protocol with Pegylated or native Asparaginase
by: Maria Agustina Perusini, et al.
Published: (2024-12-01)

Cathepsin B Is Not an Intrinsic Factor Related to Asparaginase Resistance of the Acute Lymphoblastic Leukemia REH Cell Line
by: Iris Munhoz Costa, et al.
Published: (2023-07-01)

L-asparaginase Production by Leucosporidium scottii in a Bench-Scale Bioreactor With Co-production of Lipids
by: Ignacio S. Moguel, et al.
Published: (2020-12-01)

P385: COMPARISON OF CLINICAL OUTCOMES AND ADVERSE EVENTS IN OLDER ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH NATIVE VS PEGYLATED ASPARAGINASE
by: Maria Agustina Perusini, et al.
Published: (2023-08-01)

Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India
by: Dhaarani Jayaraman, et al.
Published: (2023-10-01)

P354: REAL-WORLD ANALYSIS OF THE RISKS OF THROMBOTIC AND BLEEDING EVENTS IN PATIENTS RECEIVING PEGYLATED ASPARAGINASE FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA
by: B. Mautner, et al.
Published: (2022-06-01)

Activity of Erwinia-asparaginase after anaphylactic reaction to Peg-asparaginase
by: Maria Micaela Viña Romero, et al.
Published: (2019-03-01)

Can affinity interactions influence the partitioning of glucose-6-phosphate dehydrogenase in two-phase aqueous micellar systems?
by: André M. Lopes, et al.
Published: (2008-01-01)

Asparaginase-specific basophil recognition and activation predict Asparaginase hypersensitivity in mice
by: Sanjay Rathod, et al.
Published: (2024-04-01)

Production of L-asparaginase by filamentous fungi
by: Maria Inez de Moura Sarquis, et al.
Published: (2004-08-01)

Current state of molecular and metabolic strategies for the improvement of L-asparaginase expression in heterologous systems
by: Nicolás Lefin, et al.
Published: (2023-06-01)

National Italian Delphi panel consensus: which measures are indicated to minimize pegylated-asparaginase associated toxicity during treatment of adult acute lymphoblastic leukemia?
by: Federico Lussana, et al.
Published: (2020-10-01)

POLIMEROSSOMOS VERSUS LIPOSSOMOS: A EVOLUÇÃO DA “BALA MÁGICA”
by: Alexsandra Conceição Apolinário, et al.

P352: SYMPTOMATIC VTE INCIDENCE IN ADULT ALL TREATED WITH PEG-ASPARAGINASE COMPARED TO THE NATIVE L-ASPARAGINASE IN WITH AN ASPARAGINASE-BASED PROTOCOL
by: R. Chen, et al.
Published: (2022-06-01)

Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe.
by: Qureshi, A, et al.
Published: (2010)

Selection and Optimization of Medium Components for the Efficient Production of L-Asparaginase by <i>Leucosporidium scottii</i> L115—A Psychrotolerant Yeast
by: Ignacio S. Moguel, et al.
Published: (2022-08-01)

Production of microbial L-asparaginase
by: Batool, Tahira
Published: (2016)

L-Asparaginase-Based Biosensors
by: João C. F. Nunes, et al.
Published: (2021-08-01)

Efficacy and Toxicity of Pegylated Asparaginase in the Treatment of Children and Young Adults with Acute Lymphoblastic Leukaemia: Results of the United Kingdom Medical Research Council (MRC) Trial UKALL 2003
by: Vora, A, et al.
Published: (2008)

P365: INCORPORATION OF NELARABINE (NEL), PEGYLATED ASPARAGINASE (PEG) AND VENETOCLAX (VEN) IN THE FRONTLINE THERAPY OF ADULT PATIENTS WITH T-ACUTE LYMPHOBLASTIC LEUKEMIA/T-LYMPHOBLASTIC LYMPHOMA (T-ALL/LBL)
by: F. Ravandi, et al.
Published: (2022-06-01)

Successful stem cell transplantation after nelarabine, pegylated asparaginase, vincristine, doxorubicin, and prednisone in refractory early T-cell precursor acute lymphoblastic leukemia: A case report
by: Marcela Espinoza, et al.
Published: (2023-05-01)

Development of Processes for Recombinant L-Asparaginase II Production by <i>Escherichia coli</i> Bl21 (De3): From Shaker to Bioreactors
by: Thaís Barros, et al.
Published: (2020-12-01)

Cellular and Molecular Mechanisms of Environmental Pollutants on Hematopoiesis
by: Pablo Scharf, et al.
Published: (2020-09-01)

PEG-asparaginase induced severe hypertriglyceridemia
by: Rodolfo J. Galindo, et al.
Published: (2015-08-01)

Asparaginase: an old drug with new questions
by: Daiane Keller Cecconello, et al.
Published: (2020-07-01)

Xenobiotics Delivered by Electronic Nicotine Delivery Systems: Potential Cellular and Molecular Mechanisms on the Pathogenesis of Chronic Kidney Disease
by: Pablo Scharf, et al.
Published: (2022-09-01)

Anticancer Asparaginases: Perspectives in Using Filamentous Fungi as Cell Factories
by: Pedro Henrique Dias Garcia, et al.
Published: (2023-01-01)

Determinasi dan Karakterisasi Asparaginase Daun Gynura Procumbens [Lour]: Determination and Characterization of Gynura Procumbens [Lour]: Merr Asparaginase
by: Perpustakaan UGM, i-lib
Published: (1996)

PEG-asparaginase and native Escherichia coli L-asparaginase in acute lymphoblastic leukemia in children and adolescents: a systematic review
by: Camile Valle Medawar, et al.
Published: (2020-01-01)

Sequencing and characterization of an L-asparaginase gene from a new species of Penicillium section Citrina isolated from Cerrado
by: Kellen C. R. Andrade, et al.
Published: (2021-09-01)